These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
388 related articles for article (PubMed ID: 32999024)
121. Heavy-chain CDR3-engineered B cells facilitate in vivo evaluation of HIV-1 vaccine candidates. He W; Ou T; Skamangas N; Bailey CC; Bronkema N; Guo Y; Yin Y; Kobzarenko V; Zhang X; Pan A; Liu X; Xu J; Zhang L; Allwardt AE; Mitra D; Quinlan B; Sanders RW; Choe H; Farzan M Immunity; 2023 Oct; 56(10):2408-2424.e6. PubMed ID: 37531955 [TBL] [Abstract][Full Text] [Related]
122. Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans. Williams WB; Alam SM; Ofek G; Erdmann N; Montefiori DC; Seaman MS; Wagh K; Korber B; Edwards RJ; Mansouri K; Eaton A; Cain DW; Martin M; Hwang J; Arus-Altuz A; Lu X; Cai F; Jamieson N; Parks R; Barr M; Foulger A; Anasti K; Patel P; Sammour S; Parsons RJ; Huang X; Lindenberger J; Fetics S; Janowska K; Niyongabo A; Janus BM; Astavans A; Fox CB; Mohanty I; Evangelous T; Chen Y; Berry M; Kirshner H; Van Itallie E; Saunders KO; Wiehe K; Cohen KW; McElrath MJ; Corey L; Acharya P; Walsh SR; Baden LR; Haynes BF Cell; 2024 Jun; 187(12):2919-2934.e20. PubMed ID: 38761800 [TBL] [Abstract][Full Text] [Related]
123. Early Antibody Lineage Diversification and Independent Limb Maturation Lead to Broad HIV-1 Neutralization Targeting the Env High-Mannose Patch. MacLeod DT; Choi NM; Briney B; Garces F; Ver LS; Landais E; Murrell B; Wrin T; Kilembe W; Liang CH; Ramos A; Bian CB; Wickramasinghe L; Kong L; Eren K; Wu CY; Wong CH; ; Kosakovsky Pond SL; Wilson IA; Burton DR; Poignard P Immunity; 2016 May; 44(5):1215-26. PubMed ID: 27192579 [TBL] [Abstract][Full Text] [Related]
124. HIV-1 neutralizing antibodies elicited in humans by a prefusion-stabilized envelope trimer form a reproducible class targeting fusion peptide. Wang S; Matassoli F; Zhang B; Liu T; Shen CH; Bylund T; Johnston T; Henry AR; Teng IT; Tripathi P; Becker JE; Changela A; Chaudhary R; Cheng C; Gaudinski M; Gorman J; Harris DR; Lee M; Morano NC; Novik L; O'Dell S; Olia AS; Parchment DK; Rawi R; Roberts-Torres J; Stephens T; Tsybovsky Y; Wang D; Van Wazer DJ; Zhou T; Doria-Rose NA; Koup RA; Shapiro L; Douek DC; McDermott AB; Kwong PD Cell Rep; 2023 Jul; 42(7):112755. PubMed ID: 37436899 [TBL] [Abstract][Full Text] [Related]
125. Immune Monitoring Reveals Fusion Peptide Priming to Imprint Cross-Clade HIV-Neutralizing Responses with a Characteristic Early B Cell Signature. Cheng C; Duan H; Xu K; Chuang GY; Corrigan AR; Geng H; O'Dell S; Ou L; Chambers M; Changela A; Chen X; Foulds KE; Sarfo EK; Jafari AJ; Hill KR; Kong R; Liu K; Todd JP; Tsybovsky Y; Verardi R; Wang S; Wang Y; Wu W; Zhou T; ; Arnold FJ; Doria-Rose NA; Koup RA; McDermott AB; Scorpio DG; Worobey M; Shapiro L; Mascola JR; Kwong PD Cell Rep; 2020 Aug; 32(5):107981. PubMed ID: 32755575 [TBL] [Abstract][Full Text] [Related]
126. Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1. Xu K; Acharya P; Kong R; Cheng C; Chuang GY; Liu K; Louder MK; O'Dell S; Rawi R; Sastry M; Shen CH; Zhang B; Zhou T; Asokan M; Bailer RT; Chambers M; Chen X; Choi CW; Dandey VP; Doria-Rose NA; Druz A; Eng ET; Farney SK; Foulds KE; Geng H; Georgiev IS; Gorman J; Hill KR; Jafari AJ; Kwon YD; Lai YT; Lemmin T; McKee K; Ohr TY; Ou L; Peng D; Rowshan AP; Sheng Z; Todd JP; Tsybovsky Y; Viox EG; Wang Y; Wei H; Yang Y; Zhou AF; Chen R; Yang L; Scorpio DG; McDermott AB; Shapiro L; Carragher B; Potter CS; Mascola JR; Kwong PD Nat Med; 2018 Jun; 24(6):857-867. PubMed ID: 29867235 [TBL] [Abstract][Full Text] [Related]
127. HIV Coinfection Provides Insights for the Design of Vaccine Cocktails to Elicit Broadly Neutralizing Antibodies. Sheward DJ; Hermanus T; Murrell B; Garrett N; Abdool Karim SS; Morris L; Moore PL; Williamson C J Virol; 2022 Jul; 96(14):e0032422. PubMed ID: 35758668 [TBL] [Abstract][Full Text] [Related]
128. Identification of Non-HIV Immunogens That Bind to Germline b12 Predecessors and Prime for Elicitation of Cross-clade Neutralizing HIV-1 Antibodies. Yang Z; Li J; Liu Q; Yuan T; Zhang Y; Chen LQ; Lou Q; Sun Z; Ying H; Xu J; Dimitrov DS; Zhang MY PLoS One; 2015; 10(5):e0126428. PubMed ID: 26010511 [TBL] [Abstract][Full Text] [Related]